Skip to content
Screener

Lexicon Pharmaceuticals LXRX Short-Term Investments

Short-Term Investments at other companies

Pfizer logo
PfizerPFE
$11.37B-28.4%
Merck & Co. logo
Merck & Co.MRK
$292M-52.5%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.75B+14.9%
Cytokinetics logo
CytokineticsCYTK
$910.42M+16.2%
Mannkind logo
MannkindMNKD
$58.2M-52.3%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$76.25M-50.8%

Other financials

Income statement

See full
Revenue$692.0K-97.6%
Gross profit$653.0K-97.7%
Operating income-$26.5M-810%
Net income-$31.8M-1,077%
EPS (diluted)-$0.07-800%

Balance sheet

See full
Cash & equivalents$40.9M-18.7%
Total debt$59.2M-3.6%
Total equity$174.5M+34.8%
Total assets$250.1M+10.9%

Cash flow

See full
Operating cash flow-$9.2M—
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$1.1B+191%
Enterprise value$1.12B+187%
P/S26.5×+20.0×

Profitability

See full
Gross margin99.1%0.0pp
Operating margin-131.4%-34.2pp
Net margin-147.4%-32.8pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-40.2%-11.2pp
Debt / equity0.3×-0.1×
Current ratio13.4×+9.2×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001062822-26-000117
Line itemLevel 1Level 2Level 3Total
Cash and cash equivalents$40,924——$40,924
Short-term investments116,82532,861—149,686
Total cash and cash equivalents and short-term investments$157,749$32,861—$190,610

Item 1. Financial Statements

FAQ

What is Lexicon Pharmaceuticals's short-term investments?
Lexicon Pharmaceuticals (LXRX) reported short-term investments of $149.69M in Q2 2026.
How has Lexicon Pharmaceuticals's short-term investments changed year-over-year?
Lexicon Pharmaceuticals's short-term investments increased by 27.2% year-over-year, from $117.64M to $149.69M.
What is the long-term trend for Lexicon Pharmaceuticals's short-term investments?
Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's short-term investments has grown at a 18.9% compound annual growth rate (CAGR), from $26.01M to $61.9M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.

Ask your AI about Lexicon Pharmaceuticals's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude